And if I said the figure was nearer $55k what would you say?
Leaving the $’s aside the timeline stuff is interesting. DK has led us to expect revenues in the next few (3-4) months. Wouldn’t that suggest reimbursement approvals are well advanced or possibly known? I’ve had limited exposure to biotech/med stocks and generally exited prior to commercialisation. In your experience would a company typically announce when they have been added to the public health system purse?
Ann: Investor Update, page-35
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.002(16.7%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.2¢ | $170.2K | 13.08M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1581235 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 9880504 | 9 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |